The personalized treatment encourages the immune system to attack the tumours called glioblastomas.
15 May 2026
The personalized treatment encourages the immune system to attack the tumours called glioblastomas.
People with the brain tumour glioblastoma (shown in light yellow) survive for a median time of less than 18 months. Credit: Dr P. Marazzi/SPL
In an early clinical trial, a personalized vaccine safely stimulated the immune systems of people with a fatal type of brain tumour called glioblastoma, which has a median survival time of less than 18 months1.
Access options
A new weapon against glioblastoma, one of the most aggressive and difficult-to-treat brain tumours, has been developed by a team…
Un piccolo studio mostra un’efficacia mai vista prima in questo tumore aggressivo del cervello. Sopravvivenza allungata per la…
Personalised immunotherapy can keep disease at bay for more than four years
Researchers found patients with pancreatic cancer and bowel cancer survived more than two years after receiving the vaccine
Il glioblastoma è una delle forme di tumore cerebrale più aggressiva ed è molto difficile da trattare, soprattutto perchè non…
Una nuova arma contro il glioblastoma, uno dei tumori cerebrali più aggressivi e difficili da trattare, è stata ideata da un team…
